LRRC1 Blocking Peptide (Center)
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9BTT6 |
---|
Gene ID | 55227 |
---|---|
Other Names | Leucine-rich repeat-containing protein 1, LANO adapter protein, LAP and no PDZ protein, LRRC1, LANO |
Target/Specificity | The synthetic peptide sequence is selected from aa 318-330 of HUMAN LRRC1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | LRRC1 |
---|---|
Synonyms | LANO |
Cellular Location | Cytoplasm. Membrane; Peripheral membrane protein. Note=Localized at the basolateral side of epithelial cells |
Tissue Location | Expressed strongly in testis and placenta, followed by heart, lung, kidney, thyroid, trachea, colon, prostate and pancreas |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
References
Saito H.,et al.J. Biol. Chem. 276:32051-32055(2001).
Suzuki T.,et al.Epilepsy Res. 50:265-275(2002).
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Mungall A.J.,et al.Nature 425:805-811(2003).
Mural R.J.,et al.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.